Lantheus Holdings Stock Fair Value – Insider Activity Boosts Prospects for Lantheus Holdings Inc
November 30, 2023
☀️Trending News
Lantheus Holdings ($NASDAQ:LNTH) Inc, a company based in North Billerica, Massachusetts, has been experiencing a surge in insider activity. According to the Knox Daily, this activity could provide an advantage for the company and its shareholders. Lantheus Holdings Inc is a leading global biopharmaceutical company focused on developing, manufacturing and commercializing innovative diagnostic and therapeutic imaging products and services for the healthcare industry. The company’s current portfolio includes a range of products such as ultrasound imaging agents, MRI products, PET imaging agents, X-ray imaging agents, radiopharmaceuticals, targeted molecular revenue-generators, and other imaging products and services. The company also provides contract manufacturing services for pharmaceutical and biotechnology companies. Lantheus’ products are widely used in cardiology, neurology, oncology, women’s health and other areas to diagnose and treat various diseases and conditions.
These products are sold primarily through direct sales representatives and independent distributors in the US, Europe, Canada, and certain other countries. The company also has partnerships with other companies in the healthcare industry to provide additional imaging services. With the insider activity that Lantheus Holdings has recently experienced, analysts are expecting the company’s stock to perform well in the near future. This could be an advantageous time for potential investors to take advantage of the opportunity and purchase shares of the company’s stock. It is important to remember that investing in any company comes with inherent risks, so it is important to fully understand and research any company before investing in its stock.
Share Price
Insider activity at Lantheus Holdings Inc has recently been boosting investor confidence in the company. On Tuesday, Lantheus Holdings Inc stock opened at $71.0 and closed at $69.0, a decrease of 2.8% from the previous closing price of $71.0. This indicates that the market is responding positively to the insider activity and that investors are optimistic that Lantheus Holdings Inc is in a strong position for future growth. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Lantheus Holdings. More…
| Total Revenues | Net Income | Net Margin |
| 1.21k | 104.1 | 5.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Lantheus Holdings. More…
| Operations | Investing | Financing |
| 298.32 | -246.72 | 305.23 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Lantheus Holdings. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.52k | 822.85 | 10.21 |
Key Ratios Snapshot
Some of the financial key ratios for Lantheus Holdings are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 53.3% | 85.0% | 9.4% |
| FCF Margin | ROE | ROA |
| 21.5% | 11.4% | 4.7% |
Analysis – Lantheus Holdings Stock Fair Value
We at GoodWhale performed an analysis of LANTHEUS HOLDINGS‘s fundamentals and have determined an intrinsic value of $82.7 per share. Using our proprietary Valuation Line, we found that the current market trading price of $69.0 is undervalued by 16.6% compared to our intrinsic value. This suggests that now may be a good time to purchase shares of LANTHEUS HOLDINGS, as it is currently trading at a discount. More…
Peers
The company operates through two segments, Diagnostic Imaging and Therapeutic Imaging. The Diagnostic Imaging segment provides contrast media products and related services used in diagnostic imaging procedures. The Therapeutic Imaging segment provides nuclear imaging products and services used in molecular and nuclear medicine procedures. Lantheus Holdings Inc’s competitors include RadNet Inc, Akumin Inc, and Todos Medical Ltd. RadNet Inc is a provider of outpatient diagnostic imaging services in the United States. Akumin Inc is a provider of diagnostic imaging services in the United States and Canada. Todos Medical Ltd is a biotechnology company that develops and commercializes blood tests for the early detection of cancer.
– RadNet Inc ($NASDAQ:RDNT)
RadNet, Inc. is a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2020, RadNet operated a network of 284 outpatient imaging centers located in California, Delaware, Maryland, Massachusetts, New Jersey, New York and Virginia. RadNet’s core business is providing high-quality diagnostic imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital x-ray, diagnostic radiology and fluoroscopy, at its outpatient imaging centers.
– Akumin Inc ($NASDAQ:AKU)
Akumin Inc is a holding company that, through its subsidiaries, provides outpatient diagnostic imaging services in the United States. It operates through the following segments: Imaging Centers and Mobile Imaging. The Imaging Centers segment consists of fixed-site imaging centers that provide magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, general x-ray, and diagnostic cardiology services. The Mobile Imaging segment acquires, leases, and operates mobile imaging equipment that provides magnetic resonance imaging, computed tomography, ultrasound, and general x-ray services. The company was founded on December 12, 2005 and is headquartered in Dallas, TX.
– Todos Medical Ltd ($OTCPK:TOMDF)
Todos Medical Ltd has a market cap of 19.09M as of 2022, a Return on Equity of 43.06%. The company is engaged in the business of providing diagnostic products and services for the early detection, diagnosis and prognosis of cancer and other diseases. The company’s products and services include blood tests, tissue tests and imaging services. The company’s blood tests are used to detect the presence of cancer cells in the blood, while its tissue tests are used to detect the presence of cancer cells in the tissue. The company’s imaging services are used to detect the presence of cancer cells in the body.
Summary
Investors may want to consider additional research on Lantheus Holdings Inc, as recent insider activity has been observed. This is a positive sign for the company as it shows a strong commitment from management to the long-term success of the business.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
